|
| Weekly Top Stories |
Mon, 28 Mar 2022 |
| We have 27 articles this week. #Incannex to Acquire #APIRxPharmaceuticals USA, LLC. #Ligand New Antibody Business Prepares to Hit the #Nasdaq. #FUJIFILM Enhances Life Sciences Arm with #Shenandoah Buy. #Ligand to Spin-Off its #OmniAb Business Through Merger with #AvistaPublic Acquisition Corp. II. Publication of provisional end result for #ViforPharma tender offer: Participation rate of 94 percent. #CELLTREAT Acquires #VistaLabTechnologies. #Collegium Completes the Acquisition of #BDSI. #NAMSA Announces Intent to Acquire Contract Research Organization, #ÅKRN. #DeliverHealth Acquires Revenue Cycle Company #PresidioHealth. #FreseniusHealth Partners, #InterWellHealth, and #CricketHealth Announce $2.4B Merger. |
| Editor's Choice |
|
1.
|
Deals Relating to Cloud Increased Significantly in the Pharmaceutical Industry in H2 2021 |
|
2.
|
Global Hypercholesterolemia Drug Market Research Report to 2027 – By Mechanism of Action, Type of Disease, Drug Class and Region – ResearchAndMarkets.Com |
|
3.
|
RFID in Healthcare Market Merger and Acquisitions , Drivers, Restraints and Industry Forecast By 2027 |
|
4.
|
Polycarbonate Membrane Market In-Depth Analysis Including Key Players GE Healthcare Life Sciences (Cytiva), GVS, It4ip SA and Others |
|
5.
|
Medical Supplies Market Demand, Growth, Trends and Competitive Study – Global Industry Analysis |
| Top 10 M&A Transactions |
|
6.
|
Incannex to Acquire Apirx Pharmaceuticals USA, LLC |
|
7.
|
Ligand’s New Antibody Business Prepares to Hit the Nasdaq |
|
8.
|
FUJIFILM Enhances Life Sciences Arm with Shenandoah Buy |
|
9.
|
Ligand to Spin-Off Its OmniAb Business Through Merger with Avista Public Acquisition Corp. II |
|
10.
|
Publication of Provisional End Result for Vifor Pharma Tender Offer: Participation Rate of 94 Percent |
|
11.
|
CELLTREAT Acquires Vistalab Technologies |
|
12.
|
Collegium Completes the Acquisition of BDSI |
|
13.
|
NAMSA Announces Intent to Acquire Contract Research Organization, AKRN |
|
14.
|
DeliverHealth Acquires Revenue Cycle Company PresidioHealth |
|
15.
|
Fresenius Health Partners, InterWell Health, and Cricket Health Announce $2.4B Merger |
| Top 3 Venture Funding |
|
16.
|
UK Startup Oliva Raises $6.3M for Workplace Mental Health Platform |
|
17.
|
Podimetrics Secures $45M for SmartMat to Prevent Diabetic Amputations in High-Risk Patients |
|
18.
|
Antidote Health Secures $22M to Expand Telehealth Platform for Primary Care, Mental Health, Hypertension Care |
| Top 4 Partnerships Announcements |
|
19.
|
League Partners with Google Cloud to Accelerate Healthcare Consumer Experiences |
|
20.
|
9am.health, Ascensia Partner to Expand Virtual Diabetes Clinic |
|
21.
|
Philips & Nuvo Group Partner to Tackle Maternal Care Disparities in Rural Colorado |
|
22.
|
Digital IBS Therapy Startup MetaMe Partners to Bring PDT to Market |
|
Read More Corporate Development and M&A Activity |
|
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
|
|
 |
Editor: Ed Francis
Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.
If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073
Or connect with him at  
|
OTHER ADVISORIES
|
Advertise with us
We Reach Half Million Decision Makers in: Healthcare · IT · Retail · IndustrialAdvertise with us and reach the right audience. advertise@distilnfo.com |
Contact Us
 5760 Legacy Dr, B3-405, Plano TX 75024 |
 +1 469-270-3311
|
|
DistilINFO Publications
DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.
You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.
View in browser | Advertise | Contact Us
|
|
|
